Determination of Phenolic Compounds, Organic Volatile Molecules and Anti-Cancer Properties in Inula Viscosa L., Viscum Album L. and Raphanus Sativus L.

Year 2021, Volume: 25 Issue: 3, 647 - 662, 30.06.2021

Hafize Dilek Tepe , Aslı Uğurlu İdris Yazgan

https://doi.org/10.16984/saufenbilder.742432

Cited By: 5

Abstract

The plants elecampane (Inula Viscosa L.), mistel (Viscum album L.) and black radish seed (Raphanus Sativus L.) have been used in the treatment of common diseases worldwide as part of traditional medicine for many years. Especially in Turkey, elecampane plant is commonly used as remedy of cancer. In this study, phytochemical components of these three plants were analyzed using liquid chromatography-mass spectrometer/mass spectrometer and gas chromatography-mass spectrometer techniques. Antioxidant activity of the characterized extracts were evaluated using DPPH assay, followed by biological properties were studied using MDA-MB-231 breast cancer line. Differences in the chemical compositions of the extracts resulted in alteration in antioxidant potentials, where elecampane gave the highest antioxidant activity while black radish seed extracts did not provide any meaningful results within the test period. Cytotoxicity studies showed that chemical composition is of the most prominent factor that defined the IC50 value of each extract, where pro-oxidant and antioxidant affects were observed in relation to presence of flavonoids. Mistel extract was further tested for wound healing and apoptosis tests, and the extract was obtained as a trigger for both apoptosis and wound-healing. The findings can be a basis for refinement as fractionation of the mistel and elecampane extracts so as to obtain the best mixture that can serve as strong anticancer agent mixture.

Keywords

Elecampene, mistel, phenolic compounds, LC-MS/MS, GC-MS, anticancer.

References

• [1] D. Hanahan and R. A. Weinberg, “Review Hallmarks of Cancer : The Next Generation,” Cell, vol. 144, no. 5, pp. 646– 674, 2011.
• [2] X. Dai et al., “Breast cancer intrinsic subtype classification , clinical use and future trends,” no. May 2016, 2015.
• [3] M. Cazzaniga and B. Bonanni, “Breast Cancer Chemoprevention : Old and New Approaches,” vol. 2012, 2012.
• [4] C. Desantis, J. Ma, L. Bryan, and A. Jemal, “Breast Cancer Statistics, 2013,” 2014.
• [5] S. Goyal, N. Gupta, S. Chatterjee, and S. Nimesh, “Natural Plant Extracts as Potential Therapeutic Agents for the Treatment of Cancer,” Current Topics in Medicinal Chemistry, vol. 17, no. 2, pp. 96–106, 2016.
• [6] A. Ranjan, N. M. Fofaria, S. Kim, and S. K. Srivastava, “Modulation of signal transduction pathways by natural compounds in cancer,” Chinese Journal of Natural Medicines, vol. 13, no. 10, pp. 730–742, 2015.
• [7] F. M. Millimouno, J. Dong, L. Yang, J. Li, and X. Li, “Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature,” pp. 1081–1108, 2014.
• [8] J. Iqbal et al., “Potential phytocompounds for developing breast cancer therapeutics : Nature’s healing touch,” vol. 827, no. December 2017, pp. 125–148, 2018.
• [9] D. Bonofigilo, C. Giordano, F. De Amicis, M. Lanzino, and S. Ando, “Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.,” Mini-Reviews in Medicinal Chemistry, vol. 16, no. 8, pp. 596–604, 2016.
• [10] R. Singh Thakur and B. Ahirwar, “Natural Compounds A Weapon to Ameliorate Breast Cancer Cells: A Review,” AntiCancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), vol. 17, no. 3, pp. 374–384, 2017.
• [11] S. Uysal et al., “Novel in vitro and in silico insights of the multi-biological activities and chemical composition of Bidens tripartita L.,” Food and Chemical Toxicology, vol. 111, no. November 2017, pp. 525–536, 2018.
• [12] G. Zengin et al., “Journal of Pharmaceutical and Biomedical Analysis Chemical fingerprints , antioxidant , enzyme inhibitory , and cell assays of three extracts obtained from Sideritis ozturkii Aytac An endemic plant from Turkey,” vol. 171, pp. 118–125, 2019.
• [13] M. Fawzi, S. Yerlikaya, E. J. Llorentmartínez, and A. Uğurlu, “Pharmacological and polyphenolic profiles of Phyllanthus phillyreifolius var. commersonii Müll. Arg : An unexplored endemic species from Mauritius,” Food Research International, vol. 115, no. October 2018, pp. 425–438, 2019.
• [14] A. M. L. Seca, A. Grigore, D. C. G. A. Pinto, and A. M. S. Silva, “The genus Inula and their metabolites: From ethnopharmacological to medicinal uses,” Journal of Ethnopharmacology, vol. 154, no. 2, pp. 286–310, 2014.
• [15] F. Ertuğ, “Etnobotanik. Illustrated Flora of Turkey,” 2014.
• [16] V. Hernández, M. C. Recio, S. Máñez, R. M. Giner, and J. L. Ríos, “Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism,” Life Sciences, 2007.
• [17] S. Rozenblat, S. Grossman, M. Bergman, H. Gottlieb, Y. Cohen, and S. Dovrat, “Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines,” Biochemical Pharmacology, 2008.
• [18] M. Maoz and I. Neeman, “Effect of Inula viscosa extract on chitin synthesis in dermatophytes and Candida albicans,” Journal of Ethnopharmacology, 2000.
• [19] G. R. Schinella, H. A. Tournier, J. M. Prieto, P. Mordujovich De Buschiazzo, and J. L. Ríos, “Antioxidant activity of antiinflammatory plant extracts,” Life Sciences, 2002.
• [20] O. Danino, H. E. Gottlieb, S. Grossman, and M. Bergman, “Antioxidant activity of 1,3-dicaffeoylquinic acid isolated from Inula viscosa,” Food Research International, 2009.
• [21] G. Fontana, S. La Rocca, S. Passannanti, and M. P. Paternostro, “Sesquiterpene compounds from Inula viscosa,” Natural Product Research, vol. 21, no. 9, pp. 324– 327, 2007.
• [22] N. Zeggwagh, M. Ouahidi, A. Lemhadri, and M. Eddouks, “Study of hypoglycaemic and hypolipidemic effects of Inula viscosa L. aqueous extract in normal and diabetic rats,” Journal of Ethnopharmacolgy, vol. 108, no. 2, pp. 223–7, 2006.
• [23] S. Máñez et al., “A glycosyl analogue of diacylglycerol and other antiinflammatory constituents from Inula viscosa,” Journal of Natural Products, vol. 62, no. 4, pp. 601– 604, 1999.
• [24] T. Baytop, Türkiye’de Bitkiler ile Tedavi (Geçmişte ve Bugün) Türkiye’de Kullanılan Tıbbi Bitkiler, 40th ed. İstanbul: İ.Ü.Eczacılık Fak., 1984.
• [25] G. Ecevit Genç and N. Özhatay, “An ethnobotanical study in Çatalca (European part of Istanbul) II,” Turkish Journal of Pharmaceutical Sciences, vol. 3, no. 2, pp. 73–89, 2006.
• [26] Ş. Kültür, “Medicinal plants used in Kırklareli Province (Turkey),” Journal of Ethnopharmacology, vol. 111, no. 2, pp. 341–364, 2007.
• [27] Ç. Kizilarslan and N. Özhatay, “Wild plants used as medicinal purpose in the south part of İzmı̇t (Northwest Turkey),” Turkish Journal of Pharmaceutical Sciences, vol. 9, no. 2, pp. 199–218, 2012.
• [28] D. U. Saraç, Z. C. Özkan, and S. Akbulut, “Ethnobotanic features of Rize/Turkey province Diren,” Biological Diversity and Conservation, vol. 6, no. 3, pp. 57–66, 2013.
• [29] S. A. Sargin, E. Akçicek, and S. Selvi, “An ethnobotanical study of medicinal plants used by the local people of Alaşehir (Manisa) in Turkey,” Journal of Ethnopharmacology, 2013.
• [30] S. Karaman and Y.Z. Kocabas, “Traditional Medicinal Plants of K. Maras (Turkey),” The Sciences, vol. 1, no. 3. pp. 125–128, 2001.
• [31] A. Pieroni, H. Muenz, M. Akbulut, K. H. C. Başer, and C. Durmuşkahya, “Traditional phytotherapy and transcultural pharmacy among Turkish migrants living in Cologne, Germany,” Journal of Ethnopharmacology, 2005.
• [32] H. Jalali, A.S. Mozaffari Nejad, A.G. Ebadi, and G. Laey, “Ethnobotany and folk pharmaceutical properties of major trees or shrubs in northeast of Iran,” Asian Journal of Chemistry, vol. 21, no. 7, pp. 5632– 5638, 2009.
• [33] S. Mehmet, D. Serap, and T. Sezen, “Medicinal plants used in Dalaman (Muğla), Turkey,” Journal of Medicinal Plants Research, vol. 7, no. 28, pp. 2053– 2066, 2013.
• [34] G. Bulut, M. Zahid Bozkurt, and E. Tuzlacı, “The preliminary ethnobotanical study of medicinal plants in uşak (Turkey),” Marmara Pharmaceutical Journal, vol. 21, no. 2, pp. 305–310, 2017.
• [35] S. A. Sargin, S. Selvi, and V. López, “Ethnomedicinal plants of Sarigöl district (Manisa), Turkey,” Journal of Ethnopharmacology, 2015.
• [36] O. Adaramoye, M. Amanlou, M. HabibiRezaei, P. Pasalar, and M.M. Ali, “Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 6, pp. 427–433, 2012.
• [37] D. D. Orhan, F. S. Senol, S. Hosbas, and I. E. Orhan, “Assessment of cholinesterase and tyrosinase inhibitory and antioxidant properties of Viscum album L. samples collected from different host plants and its two principal substances,” Industrial Crops and Products, 2014.
• [38] Y. Li, Y. L. Zhao, Y. P. Yang, and X. L. Li, “Chemical constituents of Viscum album var. meridianum,” Biochemical Systematics and Ecology, 2011.
• [39] S. Loizou, I. Lekakis, G. P. Chrousos, and P. Moutsatsou, “β-Sitosterol exhibits antiinflammatory activity in human aortic endothelial cells,” Molecular Nutrition and Food Research, vol. 54, no. 4, pp. 551–558, 2010.
• [40] E. Kovacs, “The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients,” Phytotherapy Research, vol. 16, no. 2, pp. 143–147, 2002.
• [41] E. Önay-Uçar, A. Karagöz, and N. Arda, “Antioxidant activity of Viscum album ssp. album,” Fitoterapia, vol. 77, no. 7–8, pp. 556–560, 2006.
• [42] G. Schaller, K. Urech, G. Grazi, and M. Giannattasio, “Viscotoxin composition of the three European subspecies of Viscum album,” Planta Medica, vol. 64, no. 7, pp. 677–678, 1998.
• [43] D. Deliorman, I. Çalış, and F. Ergun, “A new acyclic monoterpene glucoside from Viscum album ssp. album,” Fitoterapia, 2001.
• [44] E. Lorch, “New Investigations on Flavonoids from Viscum album L. ssp. abietis, album and austriacum,” Z. Naturforsch, vol. 48, no. c, pp. 105–107, 1993.
• [45] L. X. Duan et al., “Thioglucosides from the seeds of Raphanus sativus L.,” Helvetica Chimica Acta, vol. 89, no. 12, pp. 2953– 2957, 2006.
• [46] W. Vent, “Duke, J. A., and Ayensu, E. S., Medicinal Plants of China. 2 Vols. 705 S., 1300 Strichzeichnungen. Reference Publ., Inc. Algonac. Michigan, 1985. ISBN 0- 917266-20-4.,” Feddes Repertorium, vol. 98, no. 7–8, pp. 398–398, Apr. 1985.
• [47] R. N. Chopra, S. L. Nayar, and I. . Chopra, “Glossary of Indian Medicinal Plants (Including the Supplement).” Council of Scientific and Industrial Research, New Delhi, 1986.
• [48] R.M.P. Gutiérrez and R.L. Perez, “Raphanus sativus (Radish): their chemistry and biology.,” TheScientificWorldJournal, vol. 4, no. 16, pp. 811–837, 2004.
• [49] A. Lugasi, A. Blázovics, K. Hagymási, I. Kocsis, and Á. Kéry, “Antioxidant effect of squeezed juice from black radish (Raphanus sativus L. var niger) in alimentary hyperlipidaemia in rats,” Phytotherapy Research, vol. 19, no. 7, pp. 587–591, 2005.
• [50] A. C. Gören, S. Çikrikçi, M. Çergel, and G. Bilsel, “Rapid quantitation of curcumin in turmeric via NMR and LC-tandem mass spectrometry,” Food Chemistry, vol. 113, no. 4, pp. 1239–1242, Apr. 2009.
• [51] E. J. Garcia, S. M. De Alencar, A. Reis, A. D. Loguercio, R. Helena, and M. Grande, “Antioxidant Activity by DPPH Assay of Potential Solutions to be Applied on Bleached Teeth,” Brazilian Dental Journal, vol. 23, pp. 22–27, 2012.
• [52] S. B. Kedare and R. P. Singh, “Genesis and development of DPPH method of antioxidant assay,” Journal of Food Science and Technology, vol. 48, no. 4, pp. 412–422, 2011.
• [53] K. Fidyt, A. Fiedorowicz, L. Strządała, and A. Szumny, “Β-Caryophyllene and ΒCaryophyllene Oxide—Natural Compounds of Anticancer and Analgesic Properties,” Cancer Medicine, vol. 5, no. 10, pp. 3007–3017, 2016.
• [54] F. E. Güneş, “Medical use of squalene as a natural antioxidant,” Journal of Marmara University Institute of Health Sciences, vol. 3, no. 4, p. 1, 2013.
• [55] Y.J. Xio, J. H. Su, B. W. Chen, Y. J. Tseng, Y. C. Wu, and J. H. Sheu, “Oxygenated ylangene-derived sesquiterpenoids from the soft coral lemnalia Philippinensis,” Marine Drugs, vol. 11, no. 10, pp. 3735– 3741, 2013.
• [56] V. Hanušová et al., “The effects of βcaryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice,” Biomedicine and Pharmacotherapy, vol. 95, no. July, pp. 828–836, 2017.
• [57] Z. Zerenler Çalışkan and E.N. Ay, “Synthesis of Dihydrobenzofuranone Derivatives with Biotechnological Methods,” Journal of the Turkish Chemical Society, Section A: Chemistry, vol. 5, no. 3, pp. 1221–1232, 2018.
• [58] N.H. Ryu et al., “A hexane fraction of guava leaves (Psidium guajava L.) induces anticancer activity by suppressing AKT/mammalian target of rapamycin/ribosomal p70 S6 kinase in human prostate cancer cells,” Journal of Medicinal Food, vol. 15, no. 3, pp. 231– 241, 2012.
• [59] J.D. Lambert et al., “Cytotoxic lignans from Larrea tridentata,” Phytochemistry, vol. 66, no. 7, pp. 811–815, 2005.
• [60] P. Iacopini, M. Baldi, P. Storchi, and L. Sebastiani, “Catechin, epicatechin, quercetin, rutin and resveratrol in red grape: Content, in vitro antioxidant activity and interactions,” Journal of Food Composition and Analysis, 2008.
• [61] G.S. Kelly, “Quercetin,” Alternative Medicine Review, vol. 16, no. 2, pp. 172– 194, 2011.
• [62] L. Bravo, “Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance,” Nutrition Reviews, vol. 56, no. 11, pp. 317–333, Apr. 2009.
• [63] F. BAKAR et al., “Synthesis and Characterization of Pollen Extract Mediated Gold Nanostructures,” Türk Doğa ve Fen Dergisi, vol. 9, no. 2, pp. 1–8, Nov. 2020.
• [64] D. Procházková, I. Boušová, and N. Wilhelmová, “Antioxidant and prooxidant properties of flavonoids,” Fitoterapia, vol. 82, no. 4, pp. 513–523, 2011.
• [65] M.E.A. Pinto et al., “Antifungal and antioxidant activity of fatty acid methyl esters from vegetable oils,” Anais da Academia Brasileira de Ciencias, vol. 89, no. 3, pp. 1671–1681, 2017.
• [66] Y. Sugita, K. Takao, Y. Uesawa, and H. Sakagami, “Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity,” Anticancer Research, vol. 37, no. 11, pp. 5919–5924, 2017.
• [67] M. S. Bin Sayeed and S. S. Ameen, “BetaSitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer,” Nutrition and Cancer, vol. 67, no. 8, pp. 1214–1220, 2015.
• [68] C. Constantinou, A. Papas, and A.I. Constantinou, “Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs,” International Journal of Cancer, vol. 123, no. 4, pp. 739–752, 2008.
• [69] D. R. Green and J. E. Chipuk, “NIH Public Access,” no. November, 2008.
• [70] M.C. Pagliacci, M. Smacchia, G. Migliorati, F. Grignani, C. Riccardi, and I. Nicoletti, “Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF7 human breast cancer cells,” European Journal of Cancer, vol. 30, no. 11, pp. 1675–1682, Jan. 1994.
• [71] A.B. Awad, R. Rajat, and C. S. Fink, “βsitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB231 human breast cancer cells,” Oncology Reports, vol. 10, no. 2, pp. 497–500, 2003.
• [72] B. B. Aggarwal, C. Sundaram, S. Prasad, and R. Kannappan, “Tocotrienols , the vitamin E of the 21st century : Its potential against cancer and other chronic diseases,” Biochemical Pharmacology, vol. 80, no. 11, pp. 1613–1631, 2010.
• [73] L.S. De Silva, L. H. Chuah, P. Meganathan, and J.-Y. Fu, “Tocotrienol and cancer metastasis,” Biofactors, vol. 42, no. 2, pp. 149–152, 2016.
• [74] H. Liu et al., “Inhibitory effects of γ - tocotrienol on invasion and metastasis of human gastric,” The Journal of Nutritional Biochemistry, vol. 21, no. 3, pp. 206–213, 2010.
• [75] I. G. Algayadh, V. Dronamraju, and P. W. Sylvester, “Role of Rac1/WAVE2 signaling in mediating the inhibitory effects of γ-tocotrienol on mammary cancer cell migration and invasion,” Biological and Pharmaceutical Bulletin, vol. 39, no. 12, pp. 1974–1982, 2016.